organophosphonates has been researched along with HPV Infection in 99 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (7.07) | 18.2507 |
2000's | 42 (42.42) | 29.6817 |
2010's | 47 (47.47) | 24.3611 |
2020's | 3 (3.03) | 2.80 |
Authors | Studies |
---|---|
Kerman, A; Napolitano, L; Schroedl, L; Shea, CR | 1 |
Bodnar, M; Borowczak, J; Burduk, P; Czech, J; Mackiewicz-Nartowicz, H; Rutkiewicz, P; Sinkiewicz, A; Solarz, P; Szylberg, Ł; Zwierz, A | 1 |
Richardson, BE | 1 |
Bryant, D; Fiander, AN; Hibbitts, S; Hurt, CN; Jones, SEF; Powell, N; Tristram, AJ | 1 |
Carifi, M | 1 |
Ciarrocca, K; De Rossi, SS; Jackson, LL | 1 |
Bateman, ND; Manickavasagam, J; Wu, K | 1 |
Dikkers, FG | 1 |
Clamp, PJ; Saunders, MW | 2 |
Durvasula, VS; Richter, GT | 1 |
Bolboacă, SD; Chirilă, M | 1 |
Garcia, A; Hu, A; Moore, JE; Portnoy, JE; Sanyal, S; Sataloff, RT; Saunders, S | 1 |
Balzarini, J; Flynn, ÁS; Hinsinger, K; McGuigan, C; Pertusati, F; Powell, N; Tristram, A | 1 |
Bachy, V; Grasso, M; Lawson, G; Remacle, M; Van Der Vorst, S | 1 |
Balogh, KK; Christensen, ND; Cladel, NM; Hu, J | 1 |
Dikkers, FG; San Giorgi, MR; Tjon Pian Gi, RE | 1 |
Andrei, G; De Schutter, T; Snoeck, R; Topalis, D | 1 |
Endo, K; Kondo, S; Murono, S; Nakanishi, Y; Tsuji, A; Wakisaka, N; Yoshida, H; Yoshizaki, T | 1 |
Gijsbers, S; Liekens, S; Noppen, S; Presta, M; Ronca, R; Sienaert, R; Tobia, C | 1 |
Campo, F; DE Vincentiis, M; Fusconi, M; Gallo, A; Grasso, M; Greco, A; Pagliuca, G; Remacle, M; Turchetta, R | 1 |
Akst, L; Best, SR; Bishop, JA; Hillel, A; Karatayli-Ozgursoy, S | 1 |
Baizhumanova, AS; Kim, HT | 1 |
Zeitels, SM | 1 |
Álvarez-Gallego, M; Arribas, JR; Beato, MJ; Bernardino, JI; Díaz-Almirón, M; Feíto, M; Feltes, R; González-García, J; Herranz, P; Pérez-Molina, JA; Sendagorta, E; Yllescas, M | 1 |
Andrei, G; Balzarini, J; De Schutter, T; El Amri, C; Krečmerová, M; Naesens, L; Nogueira, TC; Snoeck, R; Topalis, D | 1 |
Endo, K; Kondo, S; Murono, S; Nakanishi, Y; Tsuji, A; Wakisaka, N; Yoshizaki, T | 1 |
Andrei, G; Mertens, B; Naesens, L; Nogueira, T; Snoeck, R; Stranska, R | 1 |
Figueras Suriol, A; Pi Sala, N; Ramió Montero, E | 1 |
Brigger, M; Drejet, S; Halum, S; Parker, NP; Skopelja, E | 1 |
Battistelli, S; Benedetti, S; Catalani, S; Galati, R; Nuvoli, B; Palma, F | 1 |
Meacham, RK; Thompson, JW | 1 |
Carvalho, CM; Chapuis, F; Charlois, AL; Froehlich, P; Huot, L; Khalfallah, SA | 1 |
Bossens, M; Bucella, D; Gilles, C; Larsimont, D; Manigart, Y; Reynders, M; Rozenberg, S; Snoeck, R; Van Pachterbeke, C; Vanden Houte, K | 1 |
Burkhart, CN; Culton, DA; Morrell, DS | 1 |
Bautista, FJ; Cisneros, JM; Muñoz, RM; Prado, E | 1 |
Day, PJ; Donne, AJ; Hampson, IN; Hampson, L; He, XT; Homer, JJ; Rothera, MP; Salway, F | 1 |
Cadranel, J; Gharbi, N; Gille, T; Khalil, A; Le Tinier, JY; Rivière, F; Wislez, M | 1 |
Collette, DC; Zechel, MA | 1 |
Arjmand, EM; Ksiazek, J; Prager, JD; Sun, GH; Wood, RE | 1 |
Bartochowska, A; Jackowska, J; Józefiak, A; Kędzia, W; Szyfter, W; Wierzbicka, M | 1 |
Alsina-Gibert, M; Cañadas, MP; Darwich, E; Darwich, L; Ercilla, G; Klaustermeier, J; Mascaró, JM | 1 |
Fehér, E; Gáll, T; Gergely, L; Kis, A; Szarka, K | 1 |
Dietz, A; Dikkers, FG; Djukic, V; Eckel, HE; Friedrich, G; Golusinski, W; Hantzakos, A; Lawson, G; Remacle, M; Rihkanen, H; Tjon Pian Gi, RE | 1 |
Avril, MF; Dallot, A; Di Lucca-Christment, J; Dupin, N; Gressier, L; Jacobelli, S; Laude, H; Morini, JP; Plantier, F; Rosenberg, F; Rozenberg, F | 1 |
Gormley, RH; Kovarik, CL | 1 |
DeFatta, RA; Klaris, GE; Sataloff, JB; Sataloff, RT | 1 |
Beutner, D; Klussmann, JP; Lüers, JC; Mikolajczak, S; Quante, G; Wafaisade, A; Weissenborn, S; Wieland, U | 1 |
Fox, PA | 1 |
Friedrich, G; Graupp, M; Gugatschka, M; Hammer, G; Kiesler, K; Reckenzaun, E | 1 |
Chadha, NK; Derkay, CS; Froehlich, P; McMurray, JS; Pransky, SM; Rosen, CA; Volsky, PG | 1 |
Andrei, G; De Schutter, T; Duraffour, S; Matthys, P; Mitera, T; Naesens, L; Snoeck, R; Topalis, D; van den Oord, J | 1 |
Nathan, M | 1 |
Aaltonen, LM; Andersen, J; Brunings, JW; Chirila, M; de Gier, HH; Dietz, A; Dikkers, FG; Ferran Vilà, F; Friedrich, G; Golusinski, W; Graupp, M; Hantzakos, A; Horcasitas, R; Ilmarinen, T; Jackowska, J; Koelmel, JC; Lawson, G; Lindner, F; Remacle, M; Sittel, C; Tjon Pian Gi, RE; van den Heuvel, ER; Weichbold, V; Wierzbicka, M | 1 |
Ceruse, P; Coulombeau, B; Froehlich, P; Nusa Naiman, A | 1 |
Gangemi, JD; Johnson, JA | 2 |
Milczuk, HA | 1 |
Bartlett, ST; Cangro, CB; Drachenberg, CB; Farney, A; Fink, JC; Hirsch, H; Klassen, DK; Papadimitriou, JC; Portocarrero, M; Ramos, E; Wali, R; Weir, MR | 1 |
Bernard, HU | 1 |
DeRossi, SS; Laudenbach, J | 1 |
Kendall, KA | 1 |
Ayari, S; Bordenave, J; Bour, JB; Froehlich, P; Gagnieu, MC; Garabedian, N; Mathaut, S; Naiman, AN; Nicollas, R; Roger, G | 1 |
Hirschel, B; Pechère, M; Piguet, V; Saurat, JH; Schiffer, V; Toutous-Trellu, L | 1 |
Ferris, RL; Sirianni, N; Wang, J | 1 |
Derkay, C | 1 |
Andrei, G; Balzarini, J; De Clercq, E; Hocková, D; Holý, A; Leyssen, P; Naesens, L; Neyts, J; Pannecouque, C; Snoeck, R; Ying, C | 1 |
Lee, JH; Smith, RJ | 1 |
Clarke, RW; McCormick, M; Tasca, RA | 1 |
Aldern, KA; Beadle, JR; Corbeil, J; Hostetler, KY; Rought, S; Trahan, J | 1 |
Goh, CL; Tan, HH | 1 |
Abedipour, D; Ayari, S; Bour, JB; Coulombeau, B; Fresnel, E; Froehlich, P; Naiman, AN | 1 |
Snoeck, R | 1 |
Kottke, MD; Parker, SR | 1 |
Ayari, S; Colombeau, B; Froehlich, P; Landry, G; Naiman, AN; Nicollas, R | 1 |
Donne, AJ; Hampson, IN; Hampson, L; He, XT; Homer, JJ; Rothera, MP | 1 |
Cascone, A; Colella, G; Di Martino, F; Filippini, A; Filippini, P; Lanza, A; Martini, S; Masiello, A; Pisapia, R | 1 |
Briand, S; Milpied, B; Navas, D; Stalder, JF; Thomare, P | 1 |
Dommergues, C; Quinet, B | 1 |
Donne, AJ; Homer, JJ; Rothera, MP | 1 |
de Clercq, E; Fiten, P; Geboes, K; Janssens, J; Opdenakker, G; Rutgeerts, P; Snoeck, R; Van Cutsem, E; Van Ranst, M; Vantrappen, G | 1 |
Gross, G | 1 |
Hou, J; Major, EO | 1 |
Cockerell, CJ; Zabawski, EJ | 1 |
Delfraissy, JF; Dussaix, E; Gasnault, J; Goujard, C; Karaterki, A; Lannuzel, A; Marchadier, E; Pierre Ferey, M; Taoufik, Y | 1 |
Adriani, B; Beretta, R; Cargnel, A; Fasolo, MM; Orlando, G; Signori, R; Zanchetta, N | 1 |
Bossens, M; De Clercq, E; Muller, C; Noel, JC; Snoeck, R | 1 |
Davis, MD; Gostout, BS; McGovern, RM; Persing, DH; Pittelkow, MR; Schut, RL | 1 |
Biel, SS; Chen, S; Gelderblom, HR; Held, TK; Kurth, A; Nitsche, A; Siegert, W | 1 |
Alberti, PW; Chamberlain, DW; Dancey, DR; Downey, GP; Krajden, M; Palefsky, J | 1 |
Calista, D | 2 |
Budgeon, LR; Christensen, ND; Kreider, JW; Pickel, MD | 1 |
Andrei, G; De Clercq, E; Snoeck, R | 1 |
Bossens, M; De Clercq, E; Degreef, H; Delaere, B; Jaffe, HS; Noël, JC; Parent, D; Rooney, JF; Snoeck, R; Van Ranst, M; Wulfsohn, MS | 1 |
Clumeck, N; De Clercq, E; De Maubeuge, J; Snoeck, R; Van Laethem, Y | 1 |
Descamps, V; Mahé, E | 1 |
Abdulkarim, B; Bourhis, J; Chagraoui, H; Chouaïb, S; Deutsch, E; Eschwege, F; Maggiorella, L; Sabri, S; Thierry, J; Vainchenker, W | 1 |
18 review(s) available for organophosphonates and HPV Infection
Article | Year |
---|---|
Intralesional cidofovir as adjuvant for the successful management of aggressive respiratory papillomatosis in an infant.
Topics: Antiviral Agents; Cidofovir; Cytosine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infant; Injections, Intralesional; Laryngeal Neoplasms; Laryngoscopy; Organophosphonates; Papillomavirus Infections; Respiratory Tract Infections; Risk Assessment; Severity of Illness Index; Time Factors; Treatment Outcome | 2013 |
Insights into the mechanism of action of cidofovir and other acyclic nucleoside phosphonates against polyoma- and papillomaviruses and non-viral induced neoplasia.
Topics: Animals; Antineoplastic Agents; Antiviral Agents; Cell Line, Tumor; Cell Proliferation; Cidofovir; Cytosine; Humans; Neoplasms; Organophosphonates; Papillomaviridae; Papillomavirus Infections; Polyomavirus; Polyomavirus Infections; Tumor Suppressor Protein p53 | 2015 |
Recurrent respiratory papillomatosis by HPV: review of the literature and update on the use of cidofovir.
Topics: Antiviral Agents; Cidofovir; Cytosine; Humans; Organophosphonates; Papillomavirus Infections; Respiratory Tract Infections | 2014 |
A Systematic Review.
Topics: Adult; Angiogenesis Inhibitors; Antiviral Agents; Bevacizumab; Cidofovir; Cytosine; Humans; Injections, Intralesional; Organophosphonates; Papillomavirus Infections; Respiratory Tract Infections; Treatment Outcome | 2017 |
The management of condyloma acuminata in the pediatric population.
Topics: Adjuvants, Immunologic; Alphapapillomavirus; Aminoquinolines; Antiviral Agents; Child; Child, Preschool; Cidofovir; Cimetidine; Condylomata Acuminata; Cryotherapy; Cytosine; Dermatologic Surgical Procedures; Female; Histamine H2 Antagonists; Humans; Imiquimod; Keratolytic Agents; Laser Therapy; Lasers, Dye; Lasers, Gas; Male; Organophosphonates; Papillomavirus Infections; Podophyllotoxin; Skin; Treatment Outcome | 2009 |
Novel treatment of atypical human papillomavirus-associated epithelial hyperplasia with cidofovir.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Anus Neoplasms; Cidofovir; Cytosine; Epithelium; Fatal Outcome; HIV Infections; Humans; Male; Middle Aged; Molecular Structure; Mouth Diseases; Mouth Mucosa; Organophosphonates; Papillomavirus Infections | 2011 |
Human papillomavirus-related genital disease in the immunocompromised host: Part II.
Topics: Adjuvants, Immunologic; Alphapapillomavirus; Aminoquinolines; Antineoplastic Agents, Phytogenic; Antiviral Agents; Anus Neoplasms; Buschke-Lowenstein Tumor; Catechin; Caustics; Cidofovir; Condylomata Acuminata; Counseling; Cryotherapy; Cytosine; Female; Humans; Imiquimod; Immunocompromised Host; Male; Ointments; Organophosphonates; Papillomavirus Infections; Penile Neoplasms; Podophyllotoxin; Precancerous Conditions; Treatment Outcome; Trichloroacetic Acid; Vaginal Neoplasms; Vulvar Neoplasms; Warts | 2012 |
Treatment options for anal intraepithelial neoplasia and evidence for their effectiveness.
Topics: Adult; Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Agents; Anus Neoplasms; Cidofovir; Comorbidity; Cytosine; Female; Fluorouracil; Global Health; HIV Infections; Homosexuality, Male; Humans; Imiquimod; Incidence; Male; Organophosphonates; Papillomavirus Infections; Precancerous Conditions; Trichloroacetic Acid | 2012 |
Systematic review of intralesional cidofovir dosing regimens in the treatment of recurrent respiratory papillomatosis.
Topics: Antiviral Agents; Cidofovir; Cytosine; Humans; Injections, Intralesional; Organophosphonates; Papillomavirus Infections; Respiratory Tract Infections; Treatment Outcome | 2013 |
Established and potential strategies against papillomavirus infections.
Topics: Aminoquinolines; Antimetabolites; Antiviral Agents; Cidofovir; Cytosine; Drug Design; Fluorouracil; Humans; Imiquimod; Indoles; Interferon Inducers; Interferons; Organophosphonates; Organophosphorus Compounds; Papillomavirus Infections; Podophyllin; Viral Vaccines | 2004 |
Recurrent respiratory papillomatosis: pathogenesis to treatment.
Topics: Antineoplastic Agents; Chemotherapy, Adjuvant; Cidofovir; Cytosine; Human papillomavirus 11; Human papillomavirus 6; Humans; Indoles; Interferon-alpha; Laryngeal Neoplasms; Laser Therapy; Neoplasm Recurrence, Local; Organophosphonates; Papilloma; Papillomavirus Infections; Viral Vaccines | 2005 |
Viral infections affecting the skin in organ transplant recipients: epidemiology and current management strategies.
Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Administration Schedule; Epstein-Barr Virus Infections; Famciclovir; Foscarnet; Herpes Zoster; Herpesviridae Infections; Humans; Immunocompromised Host; Molluscum Contagiosum; Organ Transplantation; Organophosphonates; Papillomavirus Infections; Skin Diseases, Viral; Trifluridine; Valacyclovir; Valine | 2006 |
Papillomavirus and treatment.
Topics: Antiviral Agents; Carcinoma; Chemotherapy, Adjuvant; Cidofovir; Cytosine; Female; Humans; Organophosphonates; Papillomaviridae; Papillomavirus Infections; Uterine Cervical Neoplasms; Viral Vaccines; Warts | 2006 |
Scientific and clinical aspects of the use of cidofovir in recurrent respiratory papillomatosis.
Topics: Antiviral Agents; Cidofovir; Cytosine; Humans; Neoplasm Recurrence, Local; Organophosphonates; Papilloma; Papillomavirus Infections; Respiratory Tract Neoplasms | 2008 |
Therapy of human papillomavirus infection and associated epithelial tumors.
Topics: Aminoquinolines; Antineoplastic Agents; Antiviral Agents; Cidofovir; Condylomata Acuminata; Cytosine; Humans; Imiquimod; Interferon Inducers; Interferons; Laser Therapy; Neoplasms, Glandular and Epithelial; Organophosphonates; Organophosphorus Compounds; Papillomaviridae; Papillomavirus Infections; Tumor Virus Infections; Vaccines, Synthetic | 1997 |
Topical and intralesional cidofovir: a review of pharmacology and therapeutic effects.
Topics: Administration, Cutaneous; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Herpesviridae Infections; Humans; Injections, Intralesional; Injections, Intravenous; Molluscum Contagiosum; Organophosphonates; Organophosphorus Compounds; Papillomaviridae; Papillomavirus Infections; Sarcoma, Kaposi; Skin Diseases, Viral; Skin Neoplasms; Tumor Virus Infections | 1998 |
Successful treatment of juvenile laryngeal papillomatosis-related multicystic lung disease with cidofovir: case report and review of the literature.
Topics: Adult; Antiviral Agents; Biopsy; Cidofovir; Cystic Adenomatoid Malformation of Lung, Congenital; Cytosine; Diagnosis, Differential; DNA, Viral; Female; Humans; Laryngeal Neoplasms; Organophosphonates; Organophosphorus Compounds; Papilloma; Papillomaviridae; Papillomavirus Infections; Tomography, X-Ray Computed; Tumor Virus Infections | 2000 |
Cidofovir in the treatment of HPV-associated lesions.
Topics: Administration, Topical; Antiviral Agents; Apoptosis; Cell Division; Cidofovir; Cytosine; Female; Humans; Injections, Intravenous; Male; Organophosphonates; Organophosphorus Compounds; Papillomaviridae; Papillomavirus Infections; Tumor Virus Infections | 2001 |
8 trial(s) available for organophosphonates and HPV Infection
Article | Year |
---|---|
Topical cidofovir to treat high-grade anal intraepithelial neoplasia in HIV-infected patients: a pilot clinical trial.
Topics: Administration, Topical; Adult; Antiviral Agents; Anus Neoplasms; Biopsy; Carcinoma in Situ; Cidofovir; Cytosine; HIV Infections; Humans; Male; Organophosphonates; Papillomavirus Infections; Pilot Projects; Treatment Outcome | 2016 |
Topical treatment of CIN 2+ by cidofovir: results of a phase II, double-blind, prospective, placebo-controlled study.
Topics: Administration, Topical; Adult; Antineoplastic Agents; Cidofovir; Combined Modality Therapy; Conization; Contraceptive Devices, Female; Cytosine; Double-Blind Method; Female; Gels; Humans; Organophosphonates; Papillomavirus Infections; Placebos; Prospective Studies; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms | 2009 |
[Treatment of cutaneous human papilloma virus, poxvirus and herpes simplex virus infections with topical cidofovir in HIV positive patients].
Topics: Administration, Topical; Adult; Antiviral Agents; Cidofovir; Cytosine; Female; Herpes Simplex; HIV Infections; Humans; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Papillomaviridae; Papillomavirus Infections; Poxviridae Infections; Skin Diseases, Viral | 2004 |
Intermediate-term and long-term results after treatment by cidofovir and excision in juvenile laryngeal papillomatosis.
Topics: Adolescent; Adult; Antiviral Agents; Child; Child, Preschool; Cidofovir; Combined Modality Therapy; Cytosine; Female; Follow-Up Studies; Humans; Injections, Intralesional; Laryngeal Neoplasms; Laryngoscopy; Male; Organophosphonates; Papilloma; Papillomavirus Infections; Prospective Studies; Secondary Prevention; Severity of Illness Index; Treatment Outcome | 2006 |
Cidofovir, a new approach for the treatment of cervix intraepithelial neoplasia grade III (CIN III).
Topics: Adult; Antiviral Agents; Biopsy; Cervix Uteri; Cidofovir; Conization; Cytosine; Female; Humans; Immunohistochemistry; Middle Aged; Organophosphonates; Organophosphorus Compounds; Papillomaviridae; Papillomavirus Infections; Polymerase Chain Reaction; Tumor Virus Infections; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms | 2000 |
Topical cidofovir for severe cutaneous human papillomavirus and molluscum contagiosum infections in patients with HIV/AIDS. A pilot study.
Topics: Administration, Topical; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Cidofovir; Cytosine; Female; Follow-Up Studies; Humans; Male; Middle Aged; Molluscum Contagiosum; Organophosphonates; Organophosphorus Compounds; Papillomavirus Infections; Pilot Projects; Recurrence; Severity of Illness Index; Skin Diseases, Viral; Treatment Outcome; Tumor Virus Infections | 2000 |
Phase II double-blind, placebo-controlled study of the safety and efficacy of cidofovir topical gel for the treatment of patients with human papillomavirus infection.
Topics: Adult; Antiviral Agents; Cidofovir; Cytosine; Female; Humans; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Papillomaviridae; Papillomavirus Infections; Risk Factors; Treatment Outcome; Tumor Virus Infections | 2001 |
[A new antiviral for genito-anal condylomas].
Topics: Administration, Topical; Adult; Antiviral Agents; Cidofovir; Condylomata Acuminata; Cytosine; Double-Blind Method; Female Urogenital Diseases; Humans; Male Urogenital Diseases; Organophosphonates; Organophosphorus Compounds; Papillomavirus Infections; Treatment Outcome; Tumor Virus Infections | 2002 |
73 other study(ies) available for organophosphonates and HPV Infection
Article | Year |
---|---|
Topical cidofovir for benign human papillomavirus-associated skin lesions.
Topics: Alphapapillomavirus; Cidofovir; Cytosine; Humans; Organophosphonates; Papillomaviridae; Papillomavirus Infections | 2021 |
Assessment of immunomodulation and regulation of cell cycle in epithelium and stroma after Cidofovir injection in patients with recurrent respiratory papillomatosis-Pilot study.
Topics: Antiviral Agents; Cell Cycle; Cidofovir; Cytosine; Epithelium; Humans; Immunomodulation; Laryngeal Neoplasms; Organophosphonates; Papillomavirus Infections; Pilot Projects | 2023 |
Initial Experience Treating HPV-Related Laryngeal Diseases with Oral Brincidofovir: A Pilot Study.
Topics: Administration, Oral; Adult; Alphapapillomavirus; Antiviral Agents; Cytosine; Dose-Response Relationship, Drug; Humans; Laryngeal Diseases; Laryngoscopy; Larynx; Male; Middle Aged; Organophosphonates; Papillomavirus Infections; Pilot Projects | 2021 |
Human Papillomavirus DNA Methylation Predicts Response to Treatment Using Cidofovir and Imiquimod in Vulval Intraepithelial Neoplasia 3.
Topics: Aminoquinolines; Biomarkers; Carcinoma in Situ; Cidofovir; Cytosine; DNA Methylation; DNA, Viral; Drug Therapy, Combination; Female; Genes, Viral; Humans; Imiquimod; Neoplasm Staging; Organophosphonates; Papillomaviridae; Papillomavirus Infections; Promoter Regions, Genetic; ROC Curve; Treatment Outcome; Vulvar Neoplasms | 2017 |
Use of cidofovir in recurrent respiratory papillomatosis.
Topics: Antiviral Agents; Cytosine; Female; Humans; Male; Organophosphonates; Papillomavirus Infections; Respiratory Tract Infections | 2013 |
Human papillomavirus: the fundamentals of HPV for oral health care providers.
Topics: Antiviral Agents; Cidofovir; Cytosine; HIV Infections; Humans; Mouth Neoplasms; Organophosphonates; Papillomaviridae; Papillomavirus Infections; Papillomavirus Vaccines | 2013 |
Treatment of paediatric laryngeal papillomas: web survey of British Association of Paediatric Otolaryngologists.
Topics: Anticarcinogenic Agents; Antiviral Agents; Cidofovir; Combined Modality Therapy; Cytosine; Health Care Surveys; Human papillomavirus 11; Human papillomavirus 6; Humans; Injections, Intralesional; Laryngeal Neoplasms; Laser Therapy; Neoplasm Recurrence, Local; Organophosphonates; Papillomavirus Infections; Pediatrics; Practice Patterns, Physicians'; Respiratory Tract Infections; Treatment Outcome; United Kingdom | 2013 |
Letter to the editor regarding "systematic review of intralesional cidofovir dosing regimens in the treatment of recurrent respiratory papillomatosis".
Topics: Antiviral Agents; Cytosine; Humans; Organophosphonates; Papillomavirus Infections; Respiratory Tract Infections | 2013 |
Response to Dikkers letter to the editor regarding "systematic review of intralesional cidofovir dosing regimens in the treatment of recurrent respiratory papillomatosis".
Topics: Antiviral Agents; Cytosine; Humans; Organophosphonates; Papillomavirus Infections; Respiratory Tract Infections | 2013 |
Clinical efficiency of quadrivalent HPV (types 6/11/16/18) vaccine in patients with recurrent respiratory papillomatosis.
Topics: Adolescent; Adult; Antiviral Agents; Child; Child, Preschool; Cidofovir; Cytosine; Female; Follow-Up Studies; Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; Humans; Injections, Intralesional; Injections, Intramuscular; Laryngoscopy; Male; Middle Aged; Organophosphonates; Papillomavirus Infections; Papillomavirus Vaccines; Pilot Projects; Prospective Studies; Respiratory Tract Infections; Romania; Young Adult | 2014 |
Degrees of dysplasia based on viral typing in patients with cidofovir use and recurrent respiratory papillomatosis.
Topics: Antiviral Agents; Cidofovir; Cytosine; Female; Humans; Male; Middle Aged; Organophosphonates; Papillomavirus Infections; Precancerous Conditions; Recurrence; Respiratory Tract Infections; Respiratory Tract Neoplasms; Retrospective Studies | 2013 |
PMPA and PMEA prodrugs for the treatment of HIV infections and human papillomavirus (HPV) associated neoplasia and cancer.
Topics: Adenine; Antineoplastic Agents; Antiviral Agents; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; HeLa Cells; HIV; HIV Infections; Humans; Microbial Sensitivity Tests; Molecular Structure; Organophosphonates; Papillomavirus Infections; Prodrugs; Structure-Activity Relationship; Tenofovir; Tumor Cells, Cultured | 2014 |
Use of cidofovir in HPV patients with recurrent respiratory papillomatosis.
Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Cidofovir; Cytosine; Female; Humans; Injections, Intralesional; Male; Middle Aged; Organophosphonates; Papillomaviridae; Papillomavirus Infections; Respiratory Tract Infections; Retrospective Studies; Young Adult | 2014 |
Formulation of cidofovir improves the anti-papillomaviral activity of topical treatments in the CRPV/rabbit model.
Topics: Administration, Topical; Animals; Anti-Infective Agents, Local; Chemistry, Pharmaceutical; Cidofovir; Cottontail rabbit papillomavirus; Cytosine; Excipients; Organophosphonates; Papillomavirus Infections; Rabbits; Treatment Outcome; Tumor Virus Infections | 2014 |
The clinical course of recurrent respiratory papillomatosis after the use of cidofovir is influenced by multiple factors.
Topics: Cytosine; Female; Humans; Male; Organophosphonates; Papillomaviridae; Papillomavirus Infections; Respiratory Tract Infections | 2015 |
Trends in the management of recurrent respiratory papillomatosis in Japan.
Topics: Antiviral Agents; Cidofovir; Cytosine; Debridement; Disease Management; Humans; Japan; Laser Therapy; Lasers, Gas; Lasers, Solid-State; Medicine, Chinese Traditional; Organophosphonates; Otolaryngology; Papillomavirus Infections; Practice Patterns, Physicians'; Respiratory Tract Infections; Surveys and Questionnaires | 2015 |
The broad-spectrum anti-DNA virus agent cidofovir inhibits lung metastasis of virus-independent, FGF2-driven tumors.
Topics: Animals; Antiviral Agents; Apoptosis; Blotting, Western; Cell Proliferation; Cidofovir; Cytosine; Embryo, Nonmammalian; Endothelium, Vascular; Female; Fibroblast Growth Factor 2; Fibroblasts; Humans; Immunoenzyme Techniques; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, SCID; Organophosphonates; Papillomaviridae; Papillomavirus Infections; Tumor Cells, Cultured; Xenograft Model Antitumor Assays; Zebrafish | 2015 |
Risk Factors for Dysplasia in Recurrent Respiratory Papillomatosis in an Adult and Pediatric Population.
Topics: Adolescent; Adult; Age of Onset; Aged; Aged, 80 and over; Antiviral Agents; Carcinoma; Cell Transformation, Neoplastic; Child; Child, Preschool; Cidofovir; Cytosine; Humans; Infant; Middle Aged; Organophosphonates; Papillomavirus Infections; Respiratory Tract Infections; Respiratory Tract Neoplasms; Retrospective Studies; Risk Factors; Sex Factors; Smoking; Young Adult | 2016 |
Is recurrent respiratory papillomatosis a manageable or curable disease?
Topics: Adolescent; Adult; Aged; Antiviral Agents; Chemotherapy, Adjuvant; Child; Cidofovir; Combined Modality Therapy; Cytosine; Female; Humans; Injections, Intralesional; Laryngoscopy; Larynx; Laser Therapy; Male; Microsurgery; Middle Aged; Organophosphonates; Papillomavirus Infections; Postoperative Complications; Recurrence; Remission Induction; Respiratory Tract Infections; Retrospective Studies; Treatment Outcome; Voice Disorders; Voice Quality; Young Adult | 2016 |
Glottic Cancer: A Metamorphosing Disease.
Topics: Adolescent; Adult; Antiviral Agents; Carcinoma, Squamous Cell; Cidofovir; Cytosine; Diagnostic Errors; Female; Glottis; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Laryngoscopy; Laser Therapy; Lasers, Solid-State; Male; Middle Aged; Organophosphonates; Papillomavirus Infections; Respiratory Tract Infections; Retrospective Studies; Smoking; Squamous Cell Carcinoma of Head and Neck | 2016 |
Resistance to the nucleotide analogue cidofovir in HPV(+) cells: a multifactorial process involving UMP/CMP kinase 1.
Topics: ATP-Binding Cassette Transporters; Cell Line, Tumor; Cidofovir; Cytidine Triphosphate; Cytosine; Drug Resistance, Neoplasm; Female; HeLa Cells; Humans; Microbial Sensitivity Tests; Nucleoside-Phosphate Kinase; Organophosphonates; Papillomaviridae; Papillomavirus Infections; Phosphorylation; Solute Carrier Proteins; Uridine Triphosphate; Uterine Cervical Neoplasms | 2016 |
Intralesional cidofovir injection for recurrent respiratory papillomatosis in Japan.
Topics: Adult; Aged; Antiviral Agents; Cidofovir; Cytosine; Female; Human papillomavirus 6; Humans; Injections, Intralesional; Japan; Laryngeal Neoplasms; Laryngoscopy; Male; Middle Aged; Organophosphonates; Papillomavirus Infections; Respiratory Tract Infections; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Young Adult | 2016 |
Cidofovir is active against human papillomavirus positive and negative head and neck and cervical tumor cells by causing DNA damage as one of its working mechanisms.
Topics: Antiviral Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cidofovir; Cytosine; DNA Damage; Female; Head and Neck Neoplasms; HeLa Cells; Humans; Male; Organophosphonates; Papillomaviridae; Papillomavirus Infections; Squamous Cell Carcinoma of Head and Neck; Uterine Cervical Neoplasms | 2016 |
[Intralesional cidofovir in human papilomavirus infection in interdigital spaces].
Topics: Antiviral Agents; Cidofovir; Cytosine; Fingers; Humans; Infusions, Intralesional; Male; Middle Aged; Organophosphonates; Papillomavirus Infections; Skin Diseases, Viral; Warts | 2017 |
Reduced cell viability and apoptosis induction in human thyroid carcinoma and mesothelioma cells exposed to cidofovir.
Topics: Antineoplastic Agents; Antiviral Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Cidofovir; Cytosine; DNA Fragmentation; Female; Humans; Mesothelioma; Organophosphonates; Papillomavirus Infections; Polyomavirus Infections; Thyroid Neoplasms; Tumor Virus Infections; Uterine Cervical Neoplasms | 2017 |
Comparison of cidofovir and the measles, mumps, and rubella vaccine in the treatment of recurrent respiratory papillomatosis.
Topics: Adolescent; Antiviral Agents; Child; Child, Preschool; Cidofovir; Combined Modality Therapy; Cytosine; Debridement; Female; Humans; Infant; Male; Measles-Mumps-Rubella Vaccine; Organophosphonates; Papillomavirus Infections; Remission Induction; Respiratory Tract Infections; Retrospective Studies; Severity of Illness Index; Treatment Outcome | 2017 |
Prognostic factors of recurrent respiratory papillomatosis from a registry of 72 patients.
Topics: Adult; Antineoplastic Agents; Child; Child, Preschool; Cidofovir; Cytosine; Databases, Factual; Female; France; Hospitals, Teaching; Human papillomavirus 11; Human papillomavirus 6; Humans; Laryngoscopy; Male; Organophosphonates; Papilloma; Papillomavirus Infections; Prognosis; Registries; Respiratory Tract Neoplasms; Retrospective Studies | 2009 |
[Cidofovir gel 1% for treating papillomavirus lesions in a patient with congenital immunodeficiency].
Topics: Anemia, Hemolytic, Congenital; Antiviral Agents; Cidofovir; Cytosine; Female; Fingers; Gels; Hand Dermatoses; Humans; Organophosphonates; Papillomavirus Infections; Young Adult | 2010 |
Potential risk factors associated with the use of cidofovir to treat benign human papillomavirus-related disease.
Topics: Antiviral Agents; Cell Line; Cell Survival; Cidofovir; Cytosine; Gene Expression Profiling; Gene Expression Regulation; Humans; Off-Label Use; Organophosphonates; Papilloma; Papillomaviridae; Papillomavirus Infections; Respiratory Tract Neoplasms; Risk Factors; RNA | 2009 |
Treatment of recurrent respiratory papillomatosis lung involvement by cidofovir infusion.
Topics: Antiviral Agents; Cidofovir; Cytosine; Female; Humans; Infusions, Intravenous; Lung; Middle Aged; Organophosphonates; Papillomavirus Infections; Pneumonia; Respiratory Function Tests; Respiratory Tract Infections; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Inhaled cidofovir as an adjuvant therapy for recurrent respiratory papillomatosis.
Topics: Administration, Inhalation; Aerosols; Antineoplastic Agents; Antiviral Agents; Cidofovir; Cytosine; Humans; Infant; Injections, Intralesional; Male; Off-Label Use; Organophosphonates; Papillomavirus Infections; Respiratory Tract Infections | 2011 |
Effectiveness of cidofovir intralesional treatment in recurrent respiratory papillomatosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Child; Cidofovir; Cohort Studies; Cytosine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Injections, Intralesional; Laryngeal Neoplasms; Laser Therapy; Male; Middle Aged; Organophosphonates; Papillomavirus Infections; Respiratory Tract Infections; Retrospective Studies; Risk Assessment; Treatment Outcome; Young Adult | 2011 |
New human papillomavirus (HPV) types involved in epidermodysplasia verruciformis (EV) in 3 HIV-infected patients: response to topical cidofovir.
Topics: Administration, Topical; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytosine; Dose-Response Relationship, Drug; Drug Administration Schedule; Epidermodysplasia Verruciformis; Follow-Up Studies; Humans; Male; Middle Aged; Organophosphonates; Papillomaviridae; Papillomavirus Infections; Sampling Studies; Severity of Illness Index; Treatment Outcome | 2011 |
Virological failure of intralesional cidofovir therapy in recurrent respiratory papillomatosis is not associated with genetic or epigenetic changes of HPV11: complete genome comparison of sequential isolates.
Topics: Antiviral Agents; Cidofovir; Cytosine; DNA Methylation; DNA, Viral; Epigenesis, Genetic; Genome, Viral; Human papillomavirus 11; Humans; Molecular Sequence Data; Mutation; Organophosphonates; Papillomavirus Infections; Polymorphism, Single-Stranded Conformational; Respiratory Tract Infections; Sequence Analysis, DNA; Treatment Failure | 2011 |
Treatment of recurrent respiratory papillomatosis and adverse reactions following off-label use of cidofovir (Vistide®).
Topics: Adverse Drug Reaction Reporting Systems; Antiviral Agents; Cidofovir; Cytosine; Injections, Intralesional; Neoplasms; Neutropenia; Off-Label Use; Organophosphonates; Papilloma; Papillomavirus Infections; Recurrence; Renal Insufficiency; Respiratory Tract Infections | 2012 |
Anogenital pseudotumoral herpes and HIV infection: a new challenge for diagnosis and treatment.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Carcinoma, Squamous Cell; Cidofovir; Condylomata Acuminata; Cytosine; Diagnosis, Differential; Female; Foscarnet; Humans; Male; Middle Aged; Organophosphonates; Papillomavirus Infections; Thalidomide; Treatment Outcome; Tumor Virus Infections | 2012 |
Laryngeal papilloma.
Topics: Antiviral Agents; Cidofovir; Combined Modality Therapy; Cytosine; Humans; Injections, Intralesional; Laryngeal Diseases; Laryngoscopy; Male; Middle Aged; Organophosphonates; Papillomavirus Infections; Reoperation; Respiratory Tract Infections | 2012 |
The impact of cidofovir treatment on viral loads in adult recurrent respiratory papillomatosis.
Topics: Adult; Antiviral Agents; Cidofovir; Cytosine; DNA, Viral; Female; Human papillomavirus 11; Human papillomavirus 6; Humans; Laryngeal Neoplasms; Male; Middle Aged; Organophosphonates; Papillomavirus Infections; Real-Time Polymerase Chain Reaction; Respiratory Tract Infections; Retrospective Studies; Viral Load | 2012 |
Experience of 11 years use of cidofovir in recurrent respiratory papillomatosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Child; Child, Preschool; Cidofovir; Cytosine; Female; Humans; Infant; Male; Middle Aged; Organophosphonates; Papillomavirus Infections; Recurrence; Remission Induction; Respiratory Tract Infections; Young Adult | 2013 |
Current use of intralesional cidofovir for recurrent respiratory papillomatosis.
Topics: Antiviral Agents; Chemotherapy, Adjuvant; Cidofovir; Cross-Sectional Studies; Cytosine; Humans; Injections, Intralesional; Organophosphonates; Papillomavirus Infections; Practice Patterns, Physicians'; Reoperation; Respiratory Tract Infections | 2013 |
Cidofovir treatment improves the pathology caused by the growth of human papillomavirus-positive cervical carcinoma xenografts in athymic nude mice.
Topics: Animals; Antineoplastic Agents; Brain; Cachexia; Carcinoma; Cell Line, Tumor; Cidofovir; Cytokines; Cytosine; Female; Human papillomavirus 16; Humans; Kynurenine; Leukocyte Count; Liver; Mice; Mice, Nude; Organophosphonates; Papillomavirus Infections; Spleen; Splenomegaly; Tryptophan; Tumor Burden; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2013 |
Treatment of anal intraepithelial neoplasia: has it come of age?
Topics: Antiviral Agents; Anus Neoplasms; Carcinoma in Situ; Cidofovir; Cytosine; Female; HIV Infections; Humans; Male; Ointments; Organophosphonates; Papillomavirus Infections | 2013 |
Safety of intralesional cidofovir in patients with recurrent respiratory papillomatosis: an international retrospective study on 635 RRP patients.
Topics: Antiviral Agents; Cidofovir; Combined Modality Therapy; Cytosine; Female; Head and Neck Neoplasms; Humans; Injections, Intralesional; Male; Neutropenia; Off-Label Use; Organophosphonates; Papillomavirus Infections; Renal Insufficiency; Respiratory Tract Infections; Retrospective Studies; Treatment Outcome | 2013 |
Anti-cancer agents. Will cidofovir be useful against cervical lesions?
Topics: Adult; Antiviral Agents; Cidofovir; Cytosine; Female; Humans; Organophosphonates; Organophosphorus Compounds; Papillomavirus Infections; Uterine Cervical Dysplasia | 2000 |
[Anti-viral injectable treatment (cidofovir) in laryngeal papillomatosis].
Topics: Adolescent; Adult; Antiviral Agents; Child; Child, Preschool; Cidofovir; Combined Modality Therapy; Cytosine; Female; Follow-Up Studies; Humans; Infant; Injections, Intralesional; Laryngeal Neoplasms; Laryngoscopy; Laser Therapy; Male; Middle Aged; Neoadjuvant Therapy; Organophosphonates; Organophosphorus Compounds; Papillomaviridae; Papillomavirus Infections; Prospective Studies; Treatment Outcome; Tumor Virus Infections | 2002 |
Alpha interferon augments cidofovir's antiviral and antiproliferative activities.
Topics: Antiviral Agents; Blotting, Western; Cell Line, Transformed; Cidofovir; Colony Count, Microbial; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Cytosine; Drug Synergism; Humans; Interferon-alpha; Keratinocytes; Oncogene Proteins, Viral; Organophosphonates; Organophosphorus Compounds; Papillomaviridae; Papillomavirus E7 Proteins; Papillomavirus Infections; Repressor Proteins; Retinoblastoma Protein; Tumor Suppressor Protein p53; Tumor Virus Infections | 2003 |
Intralesional cidofovir for the treatment of severe juvenile recurrent respiratory papillomatosis: long-term results in 4 children.
Topics: Antiviral Agents; Child; Child, Preschool; Cidofovir; Cytosine; Female; Humans; Infant; Injections, Intralesional; Laryngeal Neoplasms; Male; Organophosphonates; Organophosphorus Compounds; Papilloma; Papillomaviridae; Papillomavirus Infections; Prospective Studies; Recurrence; Tumor Virus Infections | 2003 |
BK virus nephropathy diagnosis and treatment: experience at the University of Maryland Renal Transplant Program.
Topics: Antiviral Agents; BK Virus; Cidofovir; Cytosine; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Maryland; Organophosphonates; Organophosphorus Compounds; Papillomavirus Infections; Postoperative Complications; Retrospective Studies; Transplantation, Homologous | 2002 |
The management of oral human papillomavirus with topical cidofovir: a case report.
Topics: Administration, Topical; Adult; Antiviral Agents; Cidofovir; Cytosine; Diagnosis, Differential; Gels; HIV Infections; Humans; Male; Mouth Diseases; Organophosphonates; Organophosphorus Compounds; Papillomavirus Infections | 2004 |
Current treatment for laryngeal papillomatosis.
Topics: Adult; Antineoplastic Agents; Antiviral Agents; Child; Child, Preschool; Cidofovir; Combined Modality Therapy; Cytosine; Humans; Infant; Injections, Intralesional; Laryngeal Neoplasms; Laser Therapy; Organophosphonates; Organophosphorus Compounds; Papilloma; Papillomavirus Infections; Treatment Outcome | 2004 |
Cidofovir plasma assays after local injection in respiratory papillomatosis.
Topics: Adult; Aged; Antiviral Agents; Area Under Curve; Child; Child, Preschool; Chromatography, High Pressure Liquid; Cidofovir; Cytosine; Female; Humans; Infant; Injections, Intralesional; Larynx; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Papillomaviridae; Papillomavirus Infections; Prospective Studies | 2004 |
Antiviral activity of Cidofovir on a naturally human papillomavirus-16 infected squamous cell carcinoma of the head and neck (SCCHN) cell line improves radiation sensitivity.
Topics: Adult; Antiviral Agents; Blotting, Western; Carcinoma, Squamous Cell; Cell Survival; Cidofovir; Cytosine; Head and Neck Neoplasms; Humans; Male; Neoplasm Proteins; Oncogene Proteins, Viral; Organophosphonates; Papillomaviridae; Papillomavirus Infections; Radiation Tolerance; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2005 |
Cidofovir for recurrent respiratory papillomatosis (RRP): a re-assessment of risks.
Topics: Animals; Antiviral Agents; Carcinogens; Child; Cidofovir; Cytosine; Drug Approval; Humans; Neoplasm Recurrence, Local; Organophosphonates; Papillomavirus Infections; Respiratory Tract Neoplasms; Risk Assessment; Severity of Illness Index; United States; United States Food and Drug Administration | 2005 |
Antiviral potential of a new generation of acyclic nucleoside phosphonates, the 6-[2-(phosphonomethoxy)alkoxy]-2,4-diaminopyrimidines.
Topics: Adenoviridae; Adenoviridae Infections; Animals; Anti-HIV Agents; Antiviral Agents; Cell Line; Cidofovir; Cytosine; HIV Infections; Humans; Mice; Mice, Nude; Models, Chemical; Moloney murine sarcoma virus; Organophosphonates; Papillomaviridae; Papillomavirus Infections; Poxviridae; Poxviridae Infections; Purines; Pyrimidines; Vaccinia; Vaccinia virus | 2005 |
British Association of Paediatric Otorhinolaryngology members experience with recurrent respiratory papillomatosis.
Topics: Anticarcinogenic Agents; Antiviral Agents; Child; Cidofovir; Cytosine; Databases, Factual; Health Care Surveys; Human papillomavirus 11; Human papillomavirus 6; Humans; Indoles; Interferons; Laryngeal Neoplasms; Laser Therapy; Neoplasm Recurrence, Local; Organophosphonates; Otolaryngology; Papilloma; Papillomavirus Infections; Pediatrics; Practice Patterns, Physicians'; United Kingdom | 2006 |
Enhanced antiproliferative effects of alkoxyalkyl esters of cidofovir in human cervical cancer cells in vitro.
Topics: Antineoplastic Agents; Cell Proliferation; Cidofovir; Cytosine; Drug Screening Assays, Antitumor; Esters; Female; Fibroblasts; HeLa Cells; Humans; Organophosphonates; Papillomavirus Infections; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 2006 |
Natural history of adult-onset laryngeal papillomatosis following multiple cidofovir injections.
Topics: Adult; Antiviral Agents; Biopsy; Cidofovir; Cytosine; DNA, Viral; Female; Follow-Up Studies; Human papillomavirus 6; Humans; Injections, Intralesional; Laryngeal Neoplasms; Laryngoscopy; Male; Middle Aged; Organophosphonates; Papilloma; Papillomavirus Infections; Prospective Studies; Time Factors; Treatment Outcome | 2006 |
Intravenous cidofovir-induced resolution of disfiguring cutaneous human papillomavirus infection.
Topics: Adult; Antiviral Agents; Cidofovir; Cytosine; Humans; Injections, Intravenous; Male; Organophosphonates; Papillomavirus Infections; Skin Diseases, Viral; Treatment Outcome | 2006 |
Effects of cidofovir on a novel cell-based test system for recurrent respiratory papillomatosis.
Topics: Antiviral Agents; Blotting, Western; Cidofovir; Cytosine; Dose-Response Relationship, Drug; Flow Cytometry; Human papillomavirus 16; Human papillomavirus 6; Humans; Organophosphonates; Otorhinolaryngologic Neoplasms; Papillomavirus Infections; Reverse Transcriptase Polymerase Chain Reaction; Tumor Cells, Cultured | 2007 |
HPV oral infection. Case report of an HIV-positive Nigerian sex worker.
Topics: Adenine; Adult; Alphapapillomavirus; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Deoxycytidine; Dideoxynucleosides; Emtricitabine; Female; HIV Infections; Humans; Italy; Lamivudine; Lopinavir; Mouth Mucosa; Nigeria; Organophosphonates; Papillomavirus Infections; Pyrimidinones; Ritonavir; Sex Work; Stomatitis; Tenofovir; Treatment Refusal; Zidovudine | 2007 |
1% topical cidofovir used as last alternative to treat viral infections.
Topics: Administration, Topical; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytosine; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Molluscum Contagiosum; Organophosphonates; Papillomavirus Infections | 2008 |
[Treatment of pediatric genital condyloma].
Topics: Adult; Aminoquinolines; Antiviral Agents; Child; Cidofovir; Condylomata Acuminata; Cytosine; Humans; Imiquimod; Interferon Inducers; Keratinocytes; Organophosphonates; Papillomaviridae; Papillomavirus Infections | 2008 |
Successful treatment of a squamous papilloma of the hypopharynx-esophagus by local injections of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine.
Topics: Aged; Antiviral Agents; Cidofovir; Cytosine; Esophageal Neoplasms; Female; Humans; Hypopharyngeal Neoplasms; Organophosphonates; Organophosphorus Compounds; Papilloma; Papillomaviridae; Papillomavirus Infections; Polymerase Chain Reaction; Tumor Virus Infections | 1995 |
The efficacy of nucleoside analogs against JC virus multiplication in a persistently infected human fetal brain cell line.
Topics: Anti-HIV Agents; Antiviral Agents; Brain; Cells, Cultured; Cidofovir; Cytarabine; Cytosine; DNA, Viral; Enzyme Inhibitors; Fetus; Humans; JC Virus; Neurons; Nucleosides; Organophosphonates; Organophosphorus Compounds; Papillomavirus Infections; Topotecan; Tumor Virus Infections; Virus Replication; Zidovudine | 1998 |
Prognostic value of JC virus load in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy.
Topics: AIDS Dementia Complex; AIDS-Related Opportunistic Infections; Antiviral Agents; CD4 Lymphocyte Count; Cidofovir; Cytosine; DNA Primers; DNA Probes; DNA, Viral; Female; HIV-1; Humans; JC Virus; Male; Organophosphonates; Organophosphorus Compounds; Papillomavirus Infections; Polymerase Chain Reaction; Predictive Value of Tests; Prognosis; Statistics, Nonparametric; Tumor Virus Infections; Viral Load | 1998 |
Selective inhibition of human papillomavirus-induced cell proliferation by (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine.
Topics: Antiviral Agents; Cell Cycle; Cell Transformation, Viral; Cells, Cultured; Cidofovir; Cytosine; Humans; Keratinocytes; Nucleic Acid Synthesis Inhibitors; Organophosphonates; Organophosphorus Compounds; Papillomaviridae; Papillomavirus Infections; Tumor Virus Infections | 1999 |
Intralesional or topical cidofovir (HPMPC, VISTIDE) for the treatment of recurrent genital warts in HIV-1-infected patients.
Topics: Administration, Topical; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Condylomata Acuminata; Cytosine; DNA, Viral; HIV; Humans; Organophosphonates; Organophosphorus Compounds; Papillomaviridae; Papillomavirus Infections; Recurrence; Tumor Virus Infections; Viral Load | 1999 |
Large plantar wart caused by human papillomavirus-66 and resolution by topical cidofovir therapy.
Topics: Administration, Topical; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Biopsy; Cidofovir; Cytosine; Diagnosis, Differential; DNA, Viral; Female; Foot Dermatoses; Humans; Male; Organophosphonates; Organophosphorus Compounds; Papillomaviridae; Papillomavirus Infections; Polymerase Chain Reaction; Skin; Warts | 2000 |
Treatment of BK virus-associated hemorrhagic cystitis and simultaneous CMV reactivation with cidofovir.
Topics: Antiviral Agents; BK Virus; Cidofovir; Cystitis; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Hematuria; Humans; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Papillomavirus Infections; Virus Activation | 2000 |
Resolution of recalcitrant human papillomavirus gingival infection with topical cidofovir.
Topics: Anti-Infective Agents, Local; Antiviral Agents; Cidofovir; Cytosine; Gingival Diseases; HIV Infections; Humans; Inclusion Bodies, Viral; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Papillomaviridae; Papillomavirus Infections | 2000 |
In vivo anti-papillomavirus activity of nucleoside analogues including cidofovir on CRPV-induced rabbit papillomas.
Topics: Animals; Antiviral Agents; Cidofovir; Cottontail rabbit papillomavirus; Cytosine; Disease Models, Animal; Humans; Nucleosides; Organophosphonates; Organophosphorus Compounds; Papilloma; Papillomavirus Infections; Rabbits; Treatment Outcome; Tumor Virus Infections | 2000 |
Treatment of a bowenoid papulosis of the penis with local applications of cidofovir in a patient with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Administration, Topical; Adult; Antiviral Agents; Bowen's Disease; Cidofovir; Cytosine; Homosexuality, Male; Humans; Male; Organophosphonates; Organophosphorus Compounds; Papillomaviridae; Papillomavirus Infections; Penile Neoplasms; Skin Neoplasms; Tumor Virus Infections | 2001 |
Antiviral agent Cidofovir restores p53 function and enhances the radiosensitivity in HPV-associated cancers.
Topics: Animals; Antiviral Agents; Carcinoma; Cell Division; Cidofovir; Cyclin A; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Cytosine; Female; Head and Neck Neoplasms; Humans; Mice; Mice, Nude; Oncogene Proteins, Viral; Organophosphonates; Organophosphorus Compounds; Papillomaviridae; Papillomavirus Infections; Radiation-Sensitizing Agents; Radiation, Ionizing; Retinoblastoma Protein; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Tumor Virus Infections; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2002 |